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The effect of EGTA on the enhancement by ouabain of compound 48/80-induced secretion from mast cells was compared with the effect on the 
Na+-K+ pump activity. The time-dependent secretory enhancement by ouabain was blocked by addition of EGTA to the cell suspension concomi- 
tantly with the addition of ouabain, and EGTA caused a large increase in the pump activity. Addition of 10 nM EGTA to ouabain-treated cells 
stopped but did not reverse the enhancement. The experiments how that the effect of ouabain was due to changes in a calcium pool utilized in 
compound 48/80-induced secretion following changes in the Na+,K+ pump activity. 
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1. INTRODUCTION 
Digitalis glycosides are known to enhance the 
secretory responses of various tissues, and this is ap- 
parent in rat mast cells only in calcium-free medium 
[l-4]. The mechanism of histamine secretion induced 
by compound 48/80 from mast cells is considered to 
utilize a cellular pool of calcium that may be removed 
by EGTA [5-81. We have studied if removal of cell 
calcium available to externally added EGTA influences 
the enhanced secretory responsiveness of the cells due 
to the treatment with ouabain. 
2. MATERIALS AND METHODS 
Male Sprague-Dawley rats, 315-425 g, were used for the ex- 
periments. The rats were killed by decapitation under light ether 
anaesthesia. The mast cells were isolated by differential centrifuga- 
tion of mixed peritoneal cells in a self-generating radient of Percoll 
as described previously [9]. Following the isolation procedure, the 
mast cells were washed and suspended in a calcium-free Krebs-Ringer 
solution. The cells were kept at 4°C during the isolation procedure. A 
coulter counter (Model 134, Analys Instrument AB, Sweden) was us- 
ed to count the number of cells, and inspection of stained smears 
(Toluidine blue) were used to determine the fraction of mast cells, 
which was 97.7% + 1.3% (mean and standard deviation, n= 16). 
Mast cell suspensions pooled from l-4 rats were divided into 
samples with the same cell density in a final volume of 0.5 ml. Each 
sample contained between 1.89 x IO5 and 2.50 x 10’ cells for the 
determination of Naf, K+ pump activity and between 2.56 x 104 and 
9.87 x 104 cells for the histamine secretion experiments. The samples 
were equilibrated at 37°C in presence of potassium 4.75 mM and in 
the absence of calcium for 60 min. Then the cells were preincubated 
under various experimental conditions before the incubation with Kf 
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(s6Rb+) was carried out in order to determine the Na+, K+ pump ac- 
tivity, and before the incubation with compound 48/80 (1 pg/ml) was 
performed in order to induce the secretion of histamine. Measure- 
ment of Naf, Kf pump activity was performed as described previous- 
ly [9]. The Na+, Kf pump activity is equivalent with the cellular up- 
take of K+ (86Rbf) corrected for the ouabain-resistant uptake of K+ 
(86Rbf) taking place in presence of 1 mM ouabain (for further details 
see legends to figures). Measurement of cellular histamine release was 
performed essentially as described before [lo]. Mast cells suspensions 
in a final volume of 0.5 ml were equilibrated and then preincubated 
as mentioned above and in the legends to figures. Incubation with 
compound 48/80 for activation of the secretion mechanism lasted for 
10 min. After centrifugation, the supernatant was collected and the 
pellet was boiled for the release of residual histamine. Measurement 
of histamine was performed by the fluorimetric method [l l] omitting 
the extraction procedure. The histamine release was expressed as a 
percentage of the total histamine content of the cells. The 
Krebs-Ringer solution was calcium-free and had the following com- 
position (mM):NaCl 136.8, KC1 4.75, MgClz 1.2, Tris-HCl 12.5. All 
solutions contained bovine serum albumin, 1 mg/ml, and glucose, 1 
mg/ml. The pH was adjusted to 6.9-7.0 (37°C). 
Bovine serum albumin was supplied by Sigma Chemical Company 
(St. Louis, MO, USA), glucose by E. Merck (Darmstadt, FRG), Per- 
co11 by Pharmacia Fine Chemicals (Sweden), Ecoscint by BN Plastics 
(Helsinge, Denmark) and “Rb+ by Amersham (Buckinghamshire, 
UK). Ouabain (Mecobenzon, Denmark) and all other chemicals were 
of analytical grade. 
3. RESULTS 
In the absence of EGTA the cellular uptake of K+ 
(86Rb+) was stabilized after the preincubation period 
(60 min) at a value of 500-550 pmol/106 cells/ml 
(fig. 1). Addition of EGTA increased the uptake and it 
remained very stable at a value of 800-850 pmol/106 
cells/min. The ouabain-resistant uptake was 150 
pmol/106 cells/min, and EGTA had no effect on the 
uptake. After 60 min preincubation of the cells in a 
calcium-free medium histamine secretion was less than 
lo%, and the addition of EGTA had no effect on the 
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Fig. I. Time course of the effect of EGTA on the Na’, Kc pump ac- 
tivity. The cells were ~re~~~bated for 60 miu in calcium-free Ringer 
solution containing potassium 4.75 mM, pH 7.0 (37°C). Then a se- 
cond ~re~flcubation f the cells for l-90 min (abscissa) with (r) or 
without (0) EGTA 0.1 mM was performed before the cells were in- 
cubated with K+ (s6Rb+) for 10 min in order to measure the activity 
of the pump mechanism. The specific activity of %b+ in the suspen- 
ding medium was 0.4-1.0#%‘mf (range). This was used to calculate 
the cellular K* (%Rb+) uptake+ The ouab~n-r~~s~nt uptake (oua- 
bain 1 mM) was measured in presence ( I ) and absence (A) of EGTA. 
Ordinate scale: The cetlular uptake of K* (*‘Rb*). Mean vtiues from 
3-5 experiments are shown; vertical ines show SD. 
secretory response. Quabain induced a time-dependent 
enhancement of the secretory me~ha~sm activated by 
compound 481’80 (fig.21, This effect was completely 
blocked if EGTA was added to the cell suspension con- 
comitantly with the addition of ouabain. The inhibitory 
effect of ECTA was dependent on the concentration of 
EGTA added to the cell suspension, while 3 FM partial- 
% Hlst~rnlne retease 
Fig.2. Enhancement by oaubain of histamine secretion and reversal of 
the enhancement by EGTA. The cells were preincwbated for 60 mitt 
in calcium-free Ringer solution containing potassium 4.75 ml% pH 
7.0 (37°C). Before activation of the secretion by the addition of com- 
pound 48180, the cells were exposed to 1 mM ouabain for 5-105 min 
with (A) or without (A) the presence of 0.1 mM EGTA. Control 
values of ~is~ne secretion in the absence of ouabain and with (a) 
or withaut (0) EGTA are also shown. Control values of histamine 
secretion from mast ceils incubated in parallel in c~cium-contai~n8 
Ringer solution but in the absence of ouabain and EGTA were 
71SVs rt: 8.6% after 60 min and 69.3% f 13.3% after 120 min in- 
cubatjoa (mean and SD). Mean values from three ex~rim~ts are 
shown; verticai lines show standard deviations. 
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Fig.3. ~ose~de~ndent inhibition of the effect of ouabain on 
histam~e secretion. The cells were preincubat~ for 60 min in 
calcium-free Ringer solution containing potassium 4.75 mM, p&I 6.9 
(37°C). Before activation of the secretion by the addition of com- 
pound 48180, the cells were exposed for 105 min to EGTA, 1 ,uM to 
1 mM (abscissa) with (0) or without (0) the concomitant addition 1 
mM ouabain. Control values of histamine secretion in presence of 
ouabain was 57.8% f 7.7%, and the secretion from cells incubated 
in parallel in ~c~urn-cont~n~ng Ringer solution with potassium but 
without EGTA and without ouabain was 74S(rla I 8.6% (mean 
values and SD)_ Mean vaIues from four experiments are shown; ver- 
tical lines show SD. 
ly inhibited the effect, it was maximally inhibited by 
EGTA 10 PM (fig.3). Addition of EGTA after incuba- 
tion of the cells with ouabain for 105 min did not 
reverse the enhanced secretory responsiveness of mast 
cells due to the treatment with ouabain (Wg,4). 
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Fi.4. Effect of EGTA on the enhancement of histamine secretion by 
ouabain. The cells were preincubated for 60 min In calcium-free 
Ringer solution containing potassium 4.75 mM, pH 6.9 (37°C) 
followed by preincubation for 105 min with ouabain t mM. Then the 
cells were incubated for l-30 min with EGTA 0.01 mM f&j and 0, I 
tnM (0) before the addition of com~und 48/80. Control value of 
histamine secretion from ce& incubated in parallel in calcium- 
containing Ringer solution with potassium but without EGTA and 
without ouabain was 68.9% Z+Z 22.3% (mean value and standard 
deviation). The s~ntaneous histamine retease from control samples 
was 3.2% f 0.8%, and neither ouabain (4.2p/o 2 I.9pIG) nor oua- 
bain and EGTA (4.6% rt f .9%) changed the spontaneous histamine 
release. Mean values from four ex~~ments are shown; vertical ines 
s&w SD. 
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4. DISCUSSION 
The time dependency of the effect of ouabain on the 
secretory activity confirms previous observations [Z], 
and it supports the idea that the enhancement is due to 
changes in the ionic composition of the cell or to the ef- 
fect of this on the secretory mechanism. The identical 
effects of ouabain and potassium-free medium on the 
secretory activity [Z] argue against a direct effect of 
ouabain on the secretory mechanism. The counterac- 
ting effect of EGTA on the enhancement by ouabain 
(fig.2) may be related to our previous observation [12] 
which is confirmed by data in this study, that EGTA in- 
creased the activity of the Na+, K+ pump. This increase 
may be due to chelation of calcium ions causing calcium 
deprivation of the plasma membrane, and this seems to 
increase the permeability of the plasma membrane to 
sodium [12]. The activity of the Na+, K+ pump is the 
main mechanism that creates and maintains the polari- 
zation of the plasma membrane of rat mast cells [ 131. It 
has been proposed that depol~ization of the plasma 
membrane by inhibition of the Na+, K+ pump 
mechanism may decrease the leakage of cellular calcium 
into a calcium-free medium and preserve the reactivity 
of the cells to stimulation with compound 48/80 [ 141. In 
accordance, Pocock [15] provided evidence that oua- 
bain brings about a rise in the free intracellular concen- 
tration of calcium in adrenal medullary cells. The 
cellular pool of calcium considered to be involved in 
compound 48/80-induced secretion of histamine is 
known to be unavailable for the secretory mechanism 
by pretreatment of the cells with a calcium chelator 
[5-81. The present experiments argue in favour of the 
idea that the enhancement by ouabain may be due to an 
increased supply from cellular sources of calcium or 
preservation of calcium that is available for the 
stimulus-secretion coupling, and this is brought about 
by the inhibition of the Na”, K+ pump activity. 
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